Adalimumab antibody fragment in complex with tumor necrosis factor alpha #112956123
Description
Adalimumab is an anti-inflammatory medication. It binds to tumor necrosis factor-alpha TNFñ. Binding of TNFñ to the specific receptors leads to the inflammatory response in autoimmune diseases. Treatment with adalimumab reduces this inflammatory response.